Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
Multiple Sclerosis: A Disease of Affluence?.
Functional MRI Examination of Visual Pathways in Patients with Unilateral Optic Neuritis.
Defining Mild, Moderate, and Severe Pain in Persons with Multiple Sclerosis.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
High-Affinity Binding of Remyelinating Natural Autoantibodies to Myelin-Mimicking Lipid Bilayers Revealed by Nanohole Surface Plasmon Resonance.
CNS response to a second pro-inflammatory event depends on whether the primary demyelinating lesion is active or resolved.
Mixed Panniculitis Secondary to Interferon beta-1a Therapy in a Woman With Multiple Sclerosis.
"Disease modifying nutricals" for multiple sclerosis.
Validity and reliability of the Serbian version of Patient-Reported Impact of Spasticity Measure in multiple sclerosis.
ACTH gel in the treatment of multiple sclerosis exacerbation: a case study.
Oligodendroglial markers in the cuprizone model of CNS de- and remyelination.
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis.
Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis.
Protection of tregs, suppression of Th1 and th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline.
Suicide risk in multiple sclerosis: A systematic review of current literature.
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MS.
Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis.
Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica.
[Basic mechanisms of action of fingolimod in relation to multiple sclerosis].
Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study.
N-methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Schwann cells in therapy of spinal cord injuries.

Pages